Bernhard Nilica

1.1k total citations
27 papers, 855 citations indexed

About

Bernhard Nilica is a scholar working on Epidemiology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Bernhard Nilica has authored 27 papers receiving a total of 855 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 13 papers in Radiology, Nuclear Medicine and Imaging and 11 papers in Oncology. Recurrent topics in Bernhard Nilica's work include Neuroendocrine Tumor Research Advances (13 papers), Radiopharmaceutical Chemistry and Applications (12 papers) and Prostate Cancer Treatment and Research (9 papers). Bernhard Nilica is often cited by papers focused on Neuroendocrine Tumor Research Advances (13 papers), Radiopharmaceutical Chemistry and Applications (12 papers) and Prostate Cancer Treatment and Research (9 papers). Bernhard Nilica collaborates with scholars based in Austria, Germany and United States. Bernhard Nilica's co-authors include Irene Virgolini, Christian Uprimny, Alexander Kroiss, Clemens Decristoforo, Dorota Kendler, Wolfgang Horninger, Sabine Buxbaum, Jasmin Bektić, Elisabeth von Guggenberg and Margarida Rodrigues and has published in prestigious journals such as Journal of Nuclear Medicine, European Journal of Nuclear Medicine and Molecular Imaging and Health and Quality of Life Outcomes.

In The Last Decade

Bernhard Nilica

26 papers receiving 847 citations

Peers

Countries citing papers authored by Bernhard Nilica

Since Specialization

Citations

This map shows the geographic impact of Bernhard Nilica's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernhard Nilica with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernhard Nilica more than expected).

Fields of papers citing papers by Bernhard Nilica

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernhard Nilica. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernhard Nilica. The network helps show where Bernhard Nilica may publish in the future.

Co-authorship network of co-authors of Bernhard Nilica

This figure shows the co-authorship network connecting the top 25 collaborators of Bernhard Nilica. A scholar is included among the top collaborators of Bernhard Nilica based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernhard Nilica. Bernhard Nilica is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Safety, Biodistribution, and Radiation Dosimetry of the⁶⁸Ga-Labeled Minigastrin Analog DOTA-MGS5 in Patients with Advanced Medullary Thyroid Cancer and Other Neuroendocrine Tumors 2025 ·Journal of Nuclear Medicine ·Elisabeth von Guggenberg, (unknown), Christian Uprimny, (unknown), Boris Warwitz, (unknown), (unknown), Christine Rangger, Clemens Decristoforo, (unknown), Bernhard Nilica, Giulia Santo, Irene Virgolini	3
2	Automated Production of [68Ga]Ga-Desferrioxamine B on Two Different Synthesis Platforms 2024 ·Pharmaceutics ·(unknown), Miloš Petřík, Christine Rangger, Michael Gabriel, Hubertus Haas, Bernhard Nilica, Irene Virgolini, Clemens Decristoforo	0
3	Peptide Receptor Radionuclide Therapy in Merkel Cell Carcinoma: A Comprehensive Review 2022 ·Journal of Nuclear Medicine Technology ·Emran Askari, (unknown), Damian Wild, Ebrahim S. Delpassand, Sergio Baldari, Bernhard Nilica, Philipp E. Hartrampf, Grace Kong, Chiara Maria Grana, Martin A. Walter, Francesca Capoccetti, Pashtoon Murtaza Kasi, Jonathan Strosberg	13
4	Personalized Thera(g)nostic Approach in Patients with Paraganglioma: Peptide Receptor Radionuclide Therapy 2021 ·Bernhard Nilica, (unknown), Christian Mair, Alexander Kroiss, Michael Gabriel, Irene Virgolini	1
5	Nefrotoxicidad y hematotoxicidad un año después de cuatro ciclos de terapia con péptidos marcados con radionúclidos (PRRT) y su impacto en la planificación del tratamiento futuro. Un análisis retrospectivo 2021 ·Revista Española de Medicina Nuclear e Imagen Molecular ·Bernhard Nilica, (unknown), Josef Fritz, (unknown), Alexander Kroiss, Leonhard Gruber, Irene Virgolini	2
6	Nephrotoxicity and hematotoxicity one year after four cycles of peptide receptor radionuclide therapy (PRRT) and its impact on future treatment planning — A retrospective analysis 2021 ·Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) ·Bernhard Nilica, (unknown), Josef Fritz, (unknown), Alexander Kroiss, Leonhard Gruber, Irene Virgolini	5
7	Early Injection of Furosemide Increases Detection Rate of Local Recurrence in Prostate Cancer Patients with Biochemical Recurrence Referred for⁶⁸Ga-PSMA-11 PET/CT 2021 ·Journal of Nuclear Medicine ·Christian Uprimny, (unknown), Alexander Kroiss, Josef Fritz, Bernhard Nilica, (unknown), Clemens Decristoforo, Elisabeth von Guggenberg, Wolfgang Horninger, Irene Virgolini	17
8	The 68Ga/177Lu-theragnostic concept in PSMA-targeting of metastatic castration–resistant prostate cancer: impact of post-therapeutic whole-body scintigraphy in the follow-up 2019 ·European Journal of Nuclear Medicine and Molecular Imaging ·Johanna Maffey-Steffan, Lorenza Scarpa, (unknown), Bernhard Nilica, Christian Mair, Sabine Buxbaum, Jasmin Bektić, Elisabeth von Guggenberg, Christian Uprimny, Wolfgang Horninger, Irene Virgolini	45
9	Radiation exposure after 177Lu-DOTATATE and 177Lu-PSMA-617 therapy 2018 ·Annals of Nuclear Medicine ·Christian Mair, Boris Warwitz, (unknown), Lorenza Scarpa, Bernhard Nilica, Johanna Maffey-Steffan, Sabine Buxbaum, Irene Virgolini	16
10	Comparison of [68Ga]Ga-PSMA-11 PET/CT with [18F]NaF PET/CT in the evaluation of bone metastases in metastatic prostate cancer patients prior to radionuclide therapy 2018 ·European Journal of Nuclear Medicine and Molecular Imaging ·Christian Uprimny, (unknown), Josef Fritz, Alexander Kroiss, Bernhard Nilica, Clemens Decristoforo, Roland Haubner, Elisabeth von Guggenberg, Sabine Buxbaum, Wolfgang Horninger, Irene Virgolini	40
11	Twelve-Year Follow-up After Peptide Receptor Radionuclide Therapy 2018 ·Journal of Nuclear Medicine ·Michael Gabriel, Bernhard Nilica, Bernhard Kaiser, Irene Virgolini	31
12	Early PET imaging with [68]Ga-PSMA-11 increases the detection rate of local recurrence in prostate cancer patients with biochemical recurrence 2017 ·European Journal of Nuclear Medicine and Molecular Imaging ·Christian Uprimny, Alexander Kroiss, Josef Fritz, Clemens Decristoforo, Dorota Kendler, Elisabeth von Guggenberg, Bernhard Nilica, Johanna Maffey-Steffan, Gianpaolo di Santo, Jasmin Bektić, Wolfgang Horninger, Irene Virgolini	43
13	Direct comparison of 68Ga-DOTA-TOC and 18F-FDG PET/CT in the follow-up of patients with neuroendocrine tumour treated with the first full peptide receptor radionuclide therapy cycle 2016 ·European Journal of Nuclear Medicine and Molecular Imaging ·Bernhard Nilica, Dietmar Waitz, (unknown), Christian Uprimny, Dorota Kendler, Sabine Buxbaum, Boris Warwitz, (unknown), Benjamin Henninger, Irene Virgolini, Margarida Rodrigues	65
14	Current knowledge on the sensitivity of the 68Ga-somatostatin receptor positron emission tomography and the SUVmax reference range for management of pancreatic neuroendocrine tumours 2016 ·European Journal of Nuclear Medicine and Molecular Imaging ·Irene Virgolini, Michael Gabriel, Alexander Kroiss, Elisabeth von Guggenberg, Rupert Prommegger, Boris Warwitz, Bernhard Nilica, (unknown), Margarida Rodrigues, Christian Uprimny	29
15	Multiparametric PET imaging in thyroid malignancy characterizing tumour heterogeneity: somatostatin receptors and glucose metabolism 2015 ·European Journal of Nuclear Medicine and Molecular Imaging ·Tatjana Traub‐Weidinger, Daniel Putzer, Elisabeth von Guggenberg, Georg Dobrozemsky, Bernhard Nilica, Dorota Kendler, Reto Bale, Irene Virgolini	21
16	68Ga-PSMA PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate? 2015 ·European Journal of Nuclear Medicine and Molecular Imaging ·Francesco Ceci, Christian Uprimny, Bernhard Nilica, (unknown), Dorota Kendler, Alexander Kroiss, Jasmin Bektić, Wolfgang Horninger, Peter Lukáš, Clemens Decristoforo, Paolo Castellucci, Stefano Fanti, Irene Virgolini	222
17	Persistent quality of life impairments in differentiated thyroid cancer patients: results from a monitoring programme 2015 ·European Journal of Nuclear Medicine and Molecular Imaging ·Eva‐Maria Gamper, Lisa M. Wintner, Margarida Rodrigues, Sabine Buxbaum, Bernhard Nilica, Susanne Singer, Johannes M. Giesinger, Bernhard Holzner, Irene Virgolini	74
18	68Ga-PSMA ligand PET versus 18F-NaF PET: evaluation of response to 223Ra therapy in a prostate cancer patient 2014 ·European Journal of Nuclear Medicine and Molecular Imaging ·Christian Uprimny, Alexander Kroiss, Bernhard Nilica, Sabine Buxbaum, Clemens Decristoforo, Wolfgang Horninger, Irene Virgolini	26
19	68Ga-DOTA-TOC uptake in neuroendocrine tumour and healthy tissue: differentiation of physiological uptake and pathological processes in PET/CT 2013 ·European Journal of Nuclear Medicine and Molecular Imaging ·Alexander Kroiss, Daniel Putzer, Clemens Decristoforo, Christian Uprimny, Boris Warwitz, Bernhard Nilica, Michael Gabriel, Dorota Kendler, Dietmar Waitz, Gerlig Widmann, Irene Virgolini	73
20	PCN146 Good Prognosis, Good Quality of Life? – Longitudinal Assessment of Quality of Life in Thyroid Cancer Patients 2011 ·Value in Health ·Eva‐Maria Gamper, Johannes M. Giesinger, Anne Oberguggenberger, Lisa M. Wintner, Susanne Singer, Sabine Buxbaum, Dietmar Waitz, Daniel Putzer, Bernhard Nilica, Irene Virgolini, Bernhard Holzner	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact